Esperion Therapeutics
ESPR
#6169
Rank
S$1.14 B
Marketcap
S$4.83
Share price
-1.58%
Change (1 day)
8.12%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$1.05 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are S$1.05 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.99 B14.1%
2023-12-31S$0.87 B13.86%
2022-12-31S$0.76 B-2.01%
2021-12-31S$0.78 B31.56%
2020-12-31S$0.59 B126.73%
2019-12-31S$0.26 B198.35%
2018-12-31S$87.88 M98.26%
2017-12-31S$44.33 M84.39%
2016-12-31S$24.04 M104.45%
2015-12-31S$11.75 M-8.46%
2014-12-31S$12.84 M141.24%
2013-12-31S$5.32 M-82.37%
2012-12-31S$30.2 M183.2%
2011-12-31S$10.66 M
2002-12-31S$21.97 M0.24%
2001-12-31S$21.92 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
S$1.52 B 44.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 91.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 14,081.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$11.93 B 1,029.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.82 B-21.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.11 B-89.48%๐Ÿ‡บ๐Ÿ‡ธ USA